4de Wildt SN, Kearns GL, Hop WC, et al. Pharmacoineticsand metabolism of oral midazolam in preterm infants [J]. BrJ Clin Pharmacol, 2002, 53: 390-392.
5de Wildt SN, Kearns GL, Murry DJ, et al. Ontogeny of midazolamglucuronidation in preterm infants [J]. Eur J ClinPharmacol, 2010, 66: 165-170.
6US Food and Drug Administration. General clinical pharmacologyconsidertations for pediatric studies for drugs and biologicalproducts [S/OL]. ( 2014-12-09 ). http://www.federalregister. gov/articles/2014/12/09/2014-28716/general-clinical-pharmacology-considerations-for-pediatrics-studiesfor-drugs-and-bioligical-products.
7Reed MD, Rodarte A, Blumer JL, et al. The single-dosepharmacokinetics of midazolam and its primary metabolite inpediatric patients after oral and intravenous administration[J]. J Clin Pharmacol, 2001, 41: 1359-1369.
9Payne K, Mattheyse FJ, Liebenberg D, et al. The pharmacokineticsof midazolam in paediatric patients [J]. Eur J ClinPharmacol, 1989, 37: 267-272.
10Malinovsky JM, Populaire C, Cozian A, et al. Premedicationwith midazolam in children. Effect of intranasal, rectal andoral routes on plasma midazolam concentrations [J]. Anaesthesia,1995, 50: 351-354.
二级参考文献42
1Bolon M, Boulieu R, Flamens C, et al. Sedation induced by midazolam in intensive care: pharmacologic and pharmacokinetic aspects[J]. Ann Fr Anesth Reanim, 2002, 21 (6):478.
2Krupka E, Venisse N, Lafay C, et al. Probe of CYP3A by a single-point blood measurement after oral administration of midazolam in healthy elderly volunteers[J].Eur J Clin Pharmacol, 2006,62 (8) : 653.
3He P, Court MH, Greenblatt D J, et al. Factors influencing midazolam hydroxylation activity in human liver microsomes[J].Drug Metab Dispos, 2006,34 ( 7 ) : 1 198.
4Leucuta SE, Vlase L. Pharmacokinetics and metabolic drug interactions[J].Current Clinical Pharmacology, 2006, 1 (1):5.
5Belle D J, Callaghan JT, Gorski JC, et al.The effects of an oral contraceptive containing ethinyloestradiol and norgestrel on CYP3A activity[J]. Br J Clin Pharmacol, 2002, 53(1):67.
6Metsugi Y, Miyaji Y, Ogawara K, et al.Appearanee of double peaks in plasma concentration-time profile after oral administration depends on gastric emptying profile and weight function[J]. Pharm Res, 2008,25 (4) : 886.
7Funk W,Jakob W,Riedl T,et al.Oral preanaesthetic medication for children: double-blind randomized study of a combination of midazolam and ketamine vs midazolam or ketamine alone [J].Br J Anaesth,2000; 84:335-340.
9Malinovsky JM,Populaire C,Cozian A,et,al.Premedication with midazolam in children.Effect of intranasal,rectal and oral routes on plasma midazolam concentrations [J].Anaesthesia,1995; 50: 351-354.
10Malinovsky JM,Servin F,Cozian A,et al.Ketamine and norketamine plasma concentrations after iv,nasal and rectal administration in children[J].Br JAnesth,1996;77:203 -207.
